Search

Your search keyword '"Soo, K. C."' showing total 235 results
Start Over Author "Soo, K. C."
235 results on '"Soo, K. C."'

3. Adjuvant Hepatic Intra-arterial Iodine-131-Lipiodol Following Curative Resection of Hepatocellular Carcinoma: A Prospective Randomized Trial

Author

Chung, A. Y. F., Ooi, L. L. P. J., Machin, D., Tan, S. B., Goh, B. K. P., Wong, J. S., Chen, Y. M., Li, P. C. N., Gandhi, M., Thng, C. H., Yu, S. W. K., Tan, B. S., Lo, R. H. G., Htoo, A. M. M., Tay, K. H., Sundram, F. X., Goh, A. S. W., Chew, S. P., Liau, K. H., Chow, P. K. H., Tay, K. H., Tan, Y. M., Cheow, P. C., Ho, C. K., and Soo, K. C.

Published
2013
Full Text
View/download PDF

7. Need for global action for cancer control

Author

Boyle, P., Anderson, B. O., Andersson, L. C., Ariyaratne, Y., Auleley, G.-R., Barbacid, M., Bartelink, H., Baselga, J., Behbehani, K., Belardelli, F., Berns, A., Bishop, J., Brawley, O., Burns, H., Clanton, M., Cox, B., Currow, D., Dangou, J.-M., de Valeriola, D., Dinshaw, K., Eggermont, A., Fitzpatrick, J., Forstmane, M., Garaci, E., Gavin, A. T., Kakizoe, T., Kasler, M., Keita, N., Kerr, D., Khayat, D., Khleif, S., Khuhaprema, T., Knezevic, T., Kubinova, R., Mallath, M., Martin-Moreno, J., McCance, D., McVie, J. G., Merriman, A., Ngoma, T., Nowacki, M., Orgelbrand, J., Park, J.-G., Pierotti, M., Ashton, L. P., Puska, P., Escobar, C. V. R., Rajan, B., Rajkumar, T., Ringborg, U., Robertson, C., Rodger, A., Roovali, L., Santini, L. A., Sarhan, M., Seffrin, J., Semiglazov, V., Shrestha, B. M., Soo, K. C., Stamenic, V., Tamblyn, C., Thomas, R., Tuncer, M., Tursz, T., Vaitkiene, R., Vallejos, C., Veronesi, U., Wojtyla, A., Yach, D., Yoo, K.-Y., Zatonski, W., Zaridze, D., Zeng, Y.-X., Zhao, P., and Zheng, T.

Published
2008

45. Quality of life in patients with peritoneal surface malignancies after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Author

Chia, C. S., Tan, W. J., Wong, J. F. Sze, Tan, G. H. Ching, Lim, C., Wang, W., Sin, E. I.-l., Tham, C. K., Soo, K. C., and Teo, M. C. C.

Subjects
QUALITY of life, CYTOREDUCTIVE surgery, CANCER chemotherapy, PERITONEAL cancer, CANCER-related mortality, ABDOMINAL cancer patients, CANCER treatment
Abstract

Background An increasing number of patients are presenting with peritoneal carcinomatosis and more centers are performing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). While morbidity and mortality are shown to be acceptable, quality of life after surgery should be assessed. Methods 63 patients who had CRS and HIPEC from 2001 to 2012 and who were still alive and on follow up were included. The EORTC-QLQ-C30 was administered to the patients. Results Median age was 53 years (14-71). 44% had ovarian primaries, 21% had appendicael primaries and 19% had colorectal primaries. Median follow-up was 1.08 years (0.06-9.8). The median time from surgery to the questionnaire was 1.3 years (0.24-10.18). There was no statistical difference in scores when comparing by age, gender, recurrence, gender, PCI score, presence of a complication and type of primary cancer. Scores were highest less than 6 months after surgery, dropped subsequently but rose again after 2 years. Our patients had better scores compared to a control group of outpatient cancer patients at our institution as well as the reference EORTC group. Conclusions In keeping with previous quality of life studies done for CRS and HIPEC patients, we have shown that our patients can achieve a good quality of life after CRS and HIPEC even with recurrent disease. [ABSTRACT FROM AUTHOR]

Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results